search
Back to results

Efficacy of Oral Probiotic Administration in Patients With Chronic Periodontitis (probiotic)

Primary Purpose

-Chronic Periodontitis

Status
Unknown status
Phase
Phase 2
Locations
Chile
Study Type
Interventional
Intervention
Lactobacillus rhamnosus SP1
Talc powder
Periodontal treatment
Sponsored by
Jorge Gamonal
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for -Chronic Periodontitis focused on measuring Chronic periodontitis, Probiotics, Non- surgical treatment

Eligibility Criteria

35 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ≥14 natural teeth, excluding third molars
  • ≥10 posterior teeth
  • ≥35 years old
  • ≥ 5 teeth with periodontal sites with probing depths ≥5mm, clinical attachment loss ≥3mm
  • Bleeding on probing ≥20% of sites
  • Extensive bone loss determined radiographically

Exclusion Criteria:

  • Periodontal treatment before the time of examination
  • Systemic illness
  • Pregnancy
  • Anticoagulant, antibiotics and non- steroid anti- inflammatory therapy in the 6-month period before the study

Sites / Locations

  • Faculty of Dentistry of University of Chile

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Periodontal treatment, Probitic

Periodontal treatment, talc powder tab

Arm Description

Periodontal treatment (scaling and root planning) and one tablet containing Lactobacillus rhamnosus SP1 per day during 3 months.

Periodontal treatment (scaling and root planning) and one tablet containing talc powder per day during 3 months

Outcomes

Primary Outcome Measures

Differences of at least 1mm between groups for clinical attachment level changes

Secondary Outcome Measures

Differences between groups for probing depth changes
Differences between groups for bleeding on probing changes
Differences between groups for plaque index changes
Differences between groups for levels of Interleukin (IL)-17, IL-21, Transforming Growth Factor (TGF)- beta, IL-10, RANKL changes in gingival crevicular fluid
Differences between groups for levels of periodontal pathogens changes

Full Information

First Posted
November 1, 2014
Last Updated
June 13, 2016
Sponsor
Jorge Gamonal
search

1. Study Identification

Unique Protocol Identification Number
NCT02283736
Brief Title
Efficacy of Oral Probiotic Administration in Patients With Chronic Periodontitis
Acronym
probiotic
Official Title
Efficacy of Oral Probiotic Administration in Clinical, Immunological and Microbiological Parameters of Patients With Chronic Periodontitis Treated With Non Surgical Periodontal Treatment.
Study Type
Interventional

2. Study Status

Record Verification Date
June 2016
Overall Recruitment Status
Unknown status
Study Start Date
June 2014 (undefined)
Primary Completion Date
June 2015 (Actual)
Study Completion Date
December 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Jorge Gamonal

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this randomized placebo- controlled clinical trial is to evaluate the effects of Lactobacillus rhamnosus SP1- containing probiotic tablets as an adjunct to scaling and root planning (SRP). Material and methods: Thirty six chronic periodontitis patients will be recruited and monitored clinically, immunologically and microbiologically at baseline, 3 and 6 months after therapy. All patients will receive scaling and root planning and randomly will be assigned over an experimental (SRP + probiotic, n=18) or control (SRP + placebo, n=18) group. The tablets will be used once per day during 3 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
-Chronic Periodontitis
Keywords
Chronic periodontitis, Probiotics, Non- surgical treatment

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
36 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Periodontal treatment, Probitic
Arm Type
Experimental
Arm Description
Periodontal treatment (scaling and root planning) and one tablet containing Lactobacillus rhamnosus SP1 per day during 3 months.
Arm Title
Periodontal treatment, talc powder tab
Arm Type
Placebo Comparator
Arm Description
Periodontal treatment (scaling and root planning) and one tablet containing talc powder per day during 3 months
Intervention Type
Other
Intervention Name(s)
Lactobacillus rhamnosus SP1
Intervention Description
Tablet containing Lactobacillus rhamnosus SP1
Intervention Type
Other
Intervention Name(s)
Talc powder
Intervention Description
Tablet containing talc powder
Intervention Type
Procedure
Intervention Name(s)
Periodontal treatment
Intervention Description
Scaling and root planning
Primary Outcome Measure Information:
Title
Differences of at least 1mm between groups for clinical attachment level changes
Time Frame
baseline, 3, 6 months
Secondary Outcome Measure Information:
Title
Differences between groups for probing depth changes
Time Frame
baseline, 3, 6 month
Title
Differences between groups for bleeding on probing changes
Time Frame
baseline, 3, 6 months
Title
Differences between groups for plaque index changes
Time Frame
baseline, 3, 6 months
Title
Differences between groups for levels of Interleukin (IL)-17, IL-21, Transforming Growth Factor (TGF)- beta, IL-10, RANKL changes in gingival crevicular fluid
Time Frame
baseline, 3, 6 months
Title
Differences between groups for levels of periodontal pathogens changes
Time Frame
baseline, 3, 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ≥14 natural teeth, excluding third molars ≥10 posterior teeth ≥35 years old ≥ 5 teeth with periodontal sites with probing depths ≥5mm, clinical attachment loss ≥3mm Bleeding on probing ≥20% of sites Extensive bone loss determined radiographically Exclusion Criteria: Periodontal treatment before the time of examination Systemic illness Pregnancy Anticoagulant, antibiotics and non- steroid anti- inflammatory therapy in the 6-month period before the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jorge Gamonal, Professor
Organizational Affiliation
Faculty of Dentistry of University of Chile
Official's Role
Principal Investigator
Facility Information:
Facility Name
Faculty of Dentistry of University of Chile
City
Santiago
Country
Chile

12. IPD Sharing Statement

Learn more about this trial

Efficacy of Oral Probiotic Administration in Patients With Chronic Periodontitis

We'll reach out to this number within 24 hrs